For Canadian patients exploring GLP-1 options, genetic insights combined with clinical evaluation can support a more personalized conversation with your healthcare provider about which GLP-1 formulation, dose pathway, and monitoring strategy may be most appropriate for your individual situation
Guzman CB, Zhang XM, Liu R, Regev A, Shankar S, Garhyan P, et al
GIP receptor activation further augments insulin secretion and is proposed to influence lipid metabolism and energy expenditure, though these effects are not fully established in humans
The medication was effective but required reconstitution before each injection, which patients found inconvenient
The TGA said since this study it conducted its own independent assessment of the potential association between GLP-1 RAs and NAION and sought advice from the Advisory Committee on Medicines
doi:10.1002/dmrr.3699 Fitzgerald, J